Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07215299 · ClinicalTrials.gov registry record · NA

Temporal Interference Methods for Non-invasive Deep Brain Stimulation, Study 1.1

A NA study of Healthy Volunteers, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07215299: Recruiting NA study of Healthy Volunteers, sponsored by Indiana University.

NCT07215299 is a NA study of Healthy Volunteers that is actively recruiting participants, run by Indiana University. The registered enrollment target is 30 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07215299, a NA study of Healthy Volunteers, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

In its totality, this grant aims to develop a line of research using temporal interference (TI) electrical neurostimulation technology to understand the causal role of deep brain structures in cognition. In the short term, the investigators aim to validate and characterize the effects of TI on brain activity as measured by fMRI and demonstrate its ability to focally stimulate deep brain regions without affecting overlying cortex. In the longer term, investigators aim to use these data to resolve longstanding debates about the function of deeper brain regions and lay the foundation for future clinical applications of TI for treating addiction, Obsessive-Compulsive Disorder (OCD), Parkinson's disease, and other disorders involving deep brain dysfunction. The grant supports 2 distinct aims, each of which will be evaluated through a series of independent studies.

Primary Outcome

Brain activity in the nucleus accumbens was measured using functional magnetic resonance imaging (fMRI) during active temporal interference (TI) brain stimulation compared to sham stimulation. Activity change from baseline (no stimulation) was quantified using region-of-interest (ROI) beta estimates extracted from the nucleus accumbens. The beta estimates were derived from blood-oxygen-level-dependent (BOLD) signal changes measured during fMRI and reflect the magnitude of task-related neural act

Conditions Studied

Interventions

  • DEVICE Temporal Interference (TI) Electrical Stimulation - NAcc TI Active
  • DEVICE Temporal Interference (TI) Electrical Stimulation - NAcc TI Sham
  • DEVICE Temporal Interference (TI) Electrical Stimulation - NAcc No-TI Active
  • DEVICE Temporal Interference (TI) Electrical Stimulation - NAcc No-TI Sham

Study Locations (1)

Indiana

  • Indiana University Bloomington, Imaging Research Facility - Bloomington

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-11-12
Est. Completion 2027-02-02
Phase NA
Indiana University

890 total trials

What NCT07215299 shows while recruiting

NCT07215299 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 4 interventions - of which Temporal Interference (TI) Electrical Stimulation - NAcc TI Active is the first listed.

NCT07215299 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT07215299 about?

NCT07215299 is a clinical study titled "Temporal Interference Methods for Non-invasive Deep Brain Stimulation, Study 1.1". In its totality, this grant aims to develop a line of research using temporal interference (TI) electrical neurostimulation technology to understand the causal role of deep brain structures in cognition. In the short term, the investigators aim to validate and characterize the effects of TI on brain...

What is the current status of trial NCT07215299?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-11-12. Estimated completion is 2027-02-02.

What conditions does trial NCT07215299 study?

This clinical trial studies the following conditions: Healthy Volunteers.

What interventions are being tested in trial NCT07215299?

The interventions under investigation include: Temporal Interference (TI) Electrical Stimulation - NAcc TI Active (DEVICE), Temporal Interference (TI) Electrical Stimulation - NAcc TI Sham (DEVICE), Temporal Interference (TI) Electrical Stimulation - NAcc No-TI Active (DEVICE), Temporal Interference (TI) Electrical Stimulation - NAcc No-TI Sham (DEVICE).

Who is sponsoring clinical trial NCT07215299?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07215299 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07215299's enrollment target sits among peer trials

30 187th of 283 higher than 87 of 283 other Healthy Volunteers trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07215299, the US trial registry maintained by the National Library of Medicine. NCT07215299 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.